LHCGR and cancer: A number of studies have indicated that follicular-stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) are expressed in several cancers, suggesting that gonadotrophins may thus influence the development or progression of these diseases (11–15).